BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14910643)

  • 1. A metabolite of paludrine with high antimalarial activity.
    CARRINGTON HC; CROWTHER AF; DAVEY DG; LEVI AA; ROSE FL
    Nature; 1951 Dec; 168(4288):1080. PubMed ID: 14910643
    [No Abstract]   [Full Text] [Related]  

  • 2. Proguanil, the isolation of a metabolite with high antimalarial activity.
    CROWTHER AF; LEVI AA
    Br J Pharmacol Chemother; 1953 Mar; 8(1):93-7. PubMed ID: 13066702
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.
    ROBERTSON GI
    Trans R Soc Trop Med Hyg; 1957 Nov; 51(6):488-92. PubMed ID: 13496181
    [No Abstract]   [Full Text] [Related]  

  • 4. The mode of action of proguanil and related antimalarial drugs.
    RYLEY JF
    Br J Pharmacol Chemother; 1953 Dec; 8(4):424-30. PubMed ID: 13115632
    [No Abstract]   [Full Text] [Related]  

  • 5. Experiments with antimalarial drugs in man. I. The protective effect of proguanil (paludrine) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae.
    THOMAS AT; ROBERTSON GI; DAVEY DG
    Trans R Soc Trop Med Hyg; 1953 Jul; 47(4):338-45. PubMed ID: 13090297
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on synthetic antimalarial drugs; the blood concentrations and physiological distribution of some homologues of paludrine in relation to their antimalarial activities.
    SPINKS A
    Ann Trop Med Parasitol; 1948 Sep; 42(2):190-7. PubMed ID: 18891445
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
    Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
    Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEVELOPMENT of the antimalarial paludrine.
    Am Prof Pharm; 1946 Apr; 12():352-4. PubMed ID: 21027189
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on synthetic antimalarial drugs; hydrolytic determination of paludrine.
    SPINKS A; TOTTEY MM
    Ann Trop Med Parasitol; 1946 Apr; 40():101-12. PubMed ID: 20984397
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the chemotherapy of the human malarias; the suppressive antimalarial effect of paludrine.
    EARLE DP; BERLINER RW
    J Clin Invest; 1948 May; 27(3 Pt1):130-3. PubMed ID: 18860191
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on synthetic antimalarial drugs; determination of N1-p-chlorophenyl-N5-methyl-N5-isopropylbiguanide (4430) and N1-p-chlorophenyl-N5-isopropylbiguanide (paludrine); a preliminary report.
    SPINKS A; TOTTEY MM
    Ann Trop Med Parasitol; 1945 Dec; 39():220-4. PubMed ID: 21013254
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired paludrine-resistance in Plasmodium gallinaceum; development of resistance to paludrine and failure to develop resistance to certain other antimalarials.
    WILLIAMSON J; LOURIE EM
    Ann Trop Med Parasitol; 1947 Sep; 41(2):278-91. PubMed ID: 20267998
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on synthetic antimalarial drugs; the absorption, distribution and excretion of paludrine in experimental animals.
    SPINKS A
    Ann Trop Med Parasitol; 1947 May; 41(1):30-8. PubMed ID: 20249288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aralen and paludrine antimalarial prophylaxis in the rural regions].
    HIMPE NE; PIERQUIN L
    Ann Soc Belg Med Trop (1920); 1950 Jun; 30(2):217-46. PubMed ID: 15433059
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on synthetic antimalarial drugs; results of a preliminary investigation of the therapeutic action of 4888 (paludrine) on acute attacks of malignant tertian malaria.
    MAEGRAITH BG; ADAMS AR
    Ann Trop Med Parasitol; 1945 Dec; 39():232-6. PubMed ID: 21013256
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on synthetic antimalarial drugs; results of a preliminary investigation of the therapeutic action of 4888 (paludrine) on acute attacks of benign tertian malaria.
    ADAMS AR; MAEGRAITH BG
    Ann Trop Med Parasitol; 1945 Dec; 39():225-31. PubMed ID: 21013255
    [No Abstract]   [Full Text] [Related]  

  • 17. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
    Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH
    Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytochrome P-450 and the response to antimalarial drugs].
    Guzmán V; Carmona-Fonseca J
    Rev Panam Salud Publica; 2006 Jan; 19(1):9-22. PubMed ID: 16536934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of proguanil and its metabolite on neuromuscular and synaptic transmission.
    DALLEMAGNE MJ; PHILIPPOT E
    Br J Pharmacol Chemother; 1955 Jun; 10(2):147-52. PubMed ID: 14389651
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity of antimalarial drugs; therapeutic doses of chloroquine, paludrine, and pentaquine.
    FERBER CJ; CHINN HI
    Q Res Rep; 1948 Jan 1-Mar 31; 60():28. PubMed ID: 18912261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.